Probiotics in Eczema
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2022/07/044171
- Lead Sponsor
- RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Clinically diagnosed cases of atopic dermatitis (U.K. Working Party diagnostic criteria)
Patient with SCORAD of <50
Patients whose parents or legal representative signed the written informed consent
Treatment wash off period of atleast 2 months for systemic corticosteroids and immunosuppressants
Patient with chronic underlying disease (uncontrolled diabetes mellitus, uncontrolled hypertension, active tuberculosis) or is on immunosuppressive therapy.
Children with severe hepatic, renal or other systemic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Change in SCORAD <br/ ><br>Timepoint: 1. Change in SCORAD at 0 and 12 week <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. IL-31 level value change <br/ ><br>2. Number of replapses <br/ ><br>3. Adverse event if anyTimepoint: 1. IL-31 at 0 and 12 week <br/ ><br>2. Relapses - Need for topical corticosteroid therapy with duration in follow up <br/ ><br>3. Adverse event at each visit <br/ ><br>